The rectal approach to treatment in distal ulcerative colitis.
Anderson
F H
FH
Division of Gastroenterology, Vancouver Hospital and Health Sciences Centre, BC, Canada.
D000042:Absorption; D000285:Administration, Rectal; D000636:Aminosalicylic Acids / Q000008:administration & dosage* / Q000493:pharmacokinetics; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000493:pharmacokinetics; D002087:Butyrates / Q000008:administration & dosage / Q000378:metabolism / Q000627:therapeutic use; D020148:Butyric Acid; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000378:metabolism; D003106:Colon / Q000378:metabolism; D005232:Fatty Acids, Volatile / Q000378:metabolism; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D019804:Mesalamine; D010084:Oxidation-Reduction; D013256:Steroids / Q000008:administration & dosage / Q000493:pharmacokinetics
D000636:Aminosalicylic Acids; D000894:Anti-Inflammatory Agents, Non-Steroidal; D002087:Butyrates; D005232:Fatty Acids, Volatile; D013256:Steroids; D020148:Butyric Acid; D019804:Mesalamine